Drugs / CT0594CP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05822037 | Apr 2023 → Apr 2026 | plasma cell leukemia, plasma cell myeloma | The First Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT0594CP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05822037 ↗ |
| Modality | Cell therapy | “CT0594CP CAR-T Cells[BCMA-UCAR-T(CT0594) and CD9-UCAR-T(CT7590)]” NCT05822037 ↗ |